Alector (ALEC) Total Current Liabilities (2018 - 2026)
Alector's (ALEC) quarterly Total Current Liabilities came in at $41.0 million in Q1 2026, down 62.68% year-on-year from $109.8 million in Q1 2025, and down 41.06% on a QoQ basis from $69.5 million in Q4 2025.
Alector (ALEC) Total Current Liabilities (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Total Current Liabilities data on file, last reported at $41.0 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities fell 62.68% year-over-year to $41.0 million in Q1 2026; TTM through Mar 2026 was $41.0 million, a 62.68% decrease from a year earlier, with the FY2025 full-year figure at $69.5 million, down 44.42% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $41.0 million, down from $69.5 million in the prior quarter.
- Over the last five years, Total Current Liabilities for ALEC reached as high as $177.9 million in Q4 2023 and fell as low as $41.0 million in Q1 2026.
- Historically, Total Current Liabilities has averaged $122.2 million across 5 years, with a median of $132.3 million in 2023.
- Across the five-year window, Total Current Liabilities soared 123.03% in 2022 and tumbled 62.68% in 2026, its largest moves.
- Year by year, Total Current Liabilities stood at $93.8 million in 2022, then soared by 89.69% to $177.9 million in 2023, then declined by 29.72% to $125.1 million in 2024, then plunged by 44.42% to $69.5 million in 2025, then slumped by 41.06% to $41.0 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $41.0 million in Q1 2026, $69.5 million in Q4 2025, and $80.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Alector | 164.78 Mn | -41.74 Mn | - | 40.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.97 Mn |
| Dec 31, 2025 | 69.50 Mn |
| Sep 30, 2025 | 79.96 Mn |
| Jun 30, 2025 | 84.35 Mn |
| Mar 31, 2025 | 109.77 Mn |
| Dec 31, 2024 | 125.06 Mn |
| Sep 30, 2024 | 142.53 Mn |
| Jun 30, 2024 | 147.68 Mn |
| Mar 31, 2024 | 164.92 Mn |
| Dec 31, 2023 | 177.95 Mn |
| Sep 30, 2023 | 155.40 Mn |
| Jun 30, 2023 | 132.27 Mn |
| Mar 31, 2023 | 99.30 Mn |
| Dec 31, 2022 | 93.81 Mn |
| Sep 30, 2022 | 160.89 Mn |
| Jun 30, 2022 | 149.41 Mn |
| Mar 31, 2022 | 142.88 Mn |
| Dec 31, 2021 | 139.56 Mn |
| Sep 30, 2021 | 132.82 Mn |
| Jun 30, 2021 | 74.39 Mn |